No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects*
-
Antineoplastic Agents / classification
-
Cardiology / methods
-
Cardiology / trends
-
Cardiotoxicity*
-
Heart Diseases* / chemically induced
-
Heart Diseases* / diagnosis
-
Heart Diseases* / physiopathology
-
Heart Diseases* / therapy
-
Humans
-
Medical Oncology / methods
-
Neoplasms / drug therapy*